269 related articles for article (PubMed ID: 19298273)
1. A homozygous mutation in the ferrochelatase gene underlies erythropoietic protoporphyria associated with palmar keratoderma.
Méndez M; Poblete-Gutiérrez P; Morán-Jiménez MJ; Rodriguez ME; Garrido-Astray MC; Fontanellas A; Frank J; de Salamanca RE
Br J Dermatol; 2009 Jun; 160(6):1330-4. PubMed ID: 19298273
[No Abstract] [Full Text] [Related]
2. A homozygous mutation in the ferrochelatase gene underlies erythropoietic protoporphyria associated with palmar keratoderma--reply.
Holme SA; Anstey AV; Whatley SD; Elder GH; Badminton MN
Br J Dermatol; 2009 Oct; 161(4):966-7. PubMed ID: 19673873
[No Abstract] [Full Text] [Related]
3. A homoallelic FECH mutation in a patient with both erythropoietic protoporphyria and palmar keratoderma.
Minder EI; Schneider-Yin X; Mamet R; Horev L; Neuenschwander S; Baumer A; Austerlitz F; Puy H; Schoenfeld N
J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1349-53. PubMed ID: 20337824
[TBL] [Abstract][Full Text] [Related]
4. Seasonal palmar keratoderma in erythropoietic protoporphyria indicates autosomal recessive inheritance.
Holme SA; Whatley SD; Roberts AG; Anstey AV; Elder GH; Ead RD; Stewart MF; Farr PM; Lewis HM; Davies N; White MI; Ackroyd RS; Badminton MN
J Invest Dermatol; 2009 Mar; 129(3):599-605. PubMed ID: 18787536
[TBL] [Abstract][Full Text] [Related]
5. Exclusion of ferrochelatase gene mutations in patients with seasonal palmoplantar keratoderma.
Schimmel RJ; Van Tuyll Van Serooskerke AM; Bladergroen RS; Van Steensel AM; van Geel M; Pasmans SG; Frank J
Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):111-7. PubMed ID: 19656459
[TBL] [Abstract][Full Text] [Related]
6. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences.
Bloomer JR; Wang Y; Singhal A; Risheg H
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S36-40. PubMed ID: 16819399
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietic Protoporphyria in a Japanese Population.
Mizawa M; Makino T; Nakano H; Sawamura D; Shimizu T
Acta Derm Venereol; 2019 Jun; 99(7):634-639. PubMed ID: 30938825
[TBL] [Abstract][Full Text] [Related]
8. Novel mutation of the ferrochelatase gene in a Japanese family with erythropoietic protoporphyria.
Saito A; Okiyama N; Inoue S; Kubota N; Nakamura Y; Ishitsuka Y; Watanabe R; Nakano H; Fujisawa Y
J Dermatol; 2020 Apr; 47(4):e114-e116. PubMed ID: 32056258
[No Abstract] [Full Text] [Related]
9. A novel mutation of the FECH gene in a Chinese family with erythropoietic protoporphyria.
Zhou SN; Xiao SX; Peng ZH; Li BX; Li XL; Liu Y; Luo SJ
J Dermatol Sci; 2007 Nov; 48(2):145-7. PubMed ID: 17723290
[No Abstract] [Full Text] [Related]
10. Identification of a ferrochelatase mutation in a Chinese family with erythropoietic protoporphyria.
Kong XF; Ye J; Gao DY; Gong QM; Zhang DH; Lu ZM; Lu YM; Zhang XX
J Hepatol; 2008 Feb; 48(2):375-9. PubMed ID: 18160121
[TBL] [Abstract][Full Text] [Related]
11. Case of late-onset erythropoietic protoporphyria with myelodysplastic syndrome who has homozygous IVS3-48C polymorphism in the ferrochelatase gene.
Suzuki H; Kikuchi K; Fukuhara N; Nakano H; Aiba S
J Dermatol; 2017 Jun; 44(6):651-655. PubMed ID: 28026050
[TBL] [Abstract][Full Text] [Related]
12. Clinical, biochemical, and genetic study of 11 patients with erythropoietic protoporphyria including one with homozygous disease.
Herrero C; To-Figueras J; Badenas C; Méndez M; Serrano P; Enríquez-Salamanca R; Lecha M
Arch Dermatol; 2007 Sep; 143(9):1125-9. PubMed ID: 17875872
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietic protoporphyria a clinical and molecular study from Lebanon: Ferrochelatase a potential tumor suppressor gene in colon cancer.
Kadara H; Nemer G; Safi R; Rebeiz N; Daou L; Delbani D; Btadini W; Abbas O; Tofaili M; Bitar F; Kibbi AG; Shimomura Y; Kurban M
Clin Genet; 2017 Nov; 92(5):495-502. PubMed ID: 28075030
[TBL] [Abstract][Full Text] [Related]
14. A novel splicing mutation and haplotype analysis of the FECH gene in a Chinese family with erythropoietic protoporphyria.
Ma J; Xiao S; An J; Wang X; Xu Q; Dong Y; Feng Y; Wang J
J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):726-9. PubMed ID: 19888946
[TBL] [Abstract][Full Text] [Related]
15. Incomplete erythropoietic protoporphyria caused by a splice site modulator homozygous IVS3-48C polymorphism in the ferrochelatase gene.
Mizawa M; Makino T; Nakano H; Sawamura D; Shimizu T
Br J Dermatol; 2016 Jan; 174(1):172-5. PubMed ID: 26280465
[TBL] [Abstract][Full Text] [Related]
16. A new ferrochelatase mutation combined with low expression alleles in a Japanese patient with erythropoietic protoporphyria.
Yasui Y; Muranaka S; Tahara T; Shimizu R; Watanabe S; Horie Y; Nanba E; Uezato H; Takamiyagi A; Taketani S; Akagi R
Clin Sci (Lond); 2002 May; 102(5):501-6. PubMed ID: 11980567
[TBL] [Abstract][Full Text] [Related]
17. Ferrochelatase consisting of wild-type and mutated subunits from patients with a dominant-inherited disease, erythropoietic protoporphyria, is an active but unstable dimer.
Ohgari Y; Sawamoto M; Yamamoto M; Kohno H; Taketani S
Hum Mol Genet; 2005 Jan; 14(2):327-34. PubMed ID: 15574461
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of mutations in the ferrochelatase gene in Italian patients with erythropoietic protoporphyria.
Aurizi C; Schneider-Yin X; Sorge F; Macrì A; Minder EI; Biolcati G
Mol Genet Metab; 2007 Apr; 90(4):402-7. PubMed ID: 17196862
[TBL] [Abstract][Full Text] [Related]
19. The low expression allele (IVS3-48C) of the ferrochelatase gene leads to low enzyme activity associated with erythropoietic protoporphyria.
Tahara T; Yamamoto M; Akagi R; Harigae H; Taketani S
Int J Hematol; 2010 Dec; 92(5):769-71. PubMed ID: 21132468
[No Abstract] [Full Text] [Related]
20. A mouse model provides evidence that genetic background modulates anemia and liver injury in erythropoietic protoporphyria.
Abitbol M; Bernex F; Puy H; Jouault H; Deybach JC; Guénet JL; Montagutelli X
Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1208-16. PubMed ID: 15677551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
